Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy.
about
p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activitiesDeleted in liver cancer-1 (DLC1): an emerging metastasis suppressor geneDLC1 suppresses NF-κB activity in prostate cancer cells due to its stabilizing effect on adherens junctionsPreclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cellsCooperative antiproliferative effect of coordinated ectopic expression of DLC1 tumor suppressor protein and silencing of MYC oncogene expression in liver cancer cells: Therapeutic implicationsDLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activityDLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanismDLC1: a significant GAP in the cancer genomeDLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathwayRole of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review)Dlc1 interaction with non-muscle myosin heavy chain II-A (Myh9) and Rac1 activationA pathogenic relationship between a regulator of the actin cytoskeleton and serum response factorUncovering the rare variants of DLC1 isoform 1 and their functional effects in a Chinese sporadic congenital heart disease cohort.Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice.Detection and Clinical Significance of DLC1 Gene Methylation in Serum DNA from Colorectal Cancer Patients.DLC1 as a regulator of proliferation, invasion, cell cycle, and apoptosis in cutaneous squamous cell carcinoma.DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.
P2860
Q24317735-D933E02A-5141-41CB-813D-0F997ABA293DQ27025409-8A57E220-5C58-4DBC-9AEE-0450A3E8CB2BQ28382965-52B2B634-6AC2-4244-9BFE-ECA440450FB4Q28383203-8A25CCF6-20BE-4C6A-B01B-34C6C58708A6Q28384501-2BA5CEBE-129D-45C0-A174-5B7F30E244BCQ28385400-16A8BF60-F692-433C-A832-2AFFA7BBC6B0Q28387959-E6D48EC9-64A3-4637-B16A-AD1A599F45DEQ28390592-7C97E902-1763-46DF-92E9-352C9ADF4FCCQ28392462-7747EA72-9EEE-4244-97E8-9BF35B2FBBE9Q28394917-C7D87121-318E-4ABD-9153-584243B291EAQ28395847-29EAB4EE-A644-4191-ACEE-C976E8F48AEAQ34131490-65C5226B-66FA-4BC0-9A10-194A9D2FE03BQ35108861-F9EFD838-C1B7-42F3-87DF-112B0D350BA6Q35871976-483A8592-0D2C-474F-BAD4-E98069E43C4BQ36551119-7947D703-E35D-4292-92D6-9F6098F4F576Q39159045-7BA6833A-B5A7-4F97-BEE5-53A4AB84D269Q39200334-5FFD0FB7-F4EB-4904-A8BF-8EEC7E42111EQ39696941-0FEE7B48-D846-4712-B9FD-6DCC1D79A1F2
P2860
Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Adenovirus-mediated restoratio ...... s: prospects for gene therapy.
@en
Adenovirus-mediated restoratio ...... s: prospects for gene therapy.
@nl
type
label
Adenovirus-mediated restoratio ...... s: prospects for gene therapy.
@en
Adenovirus-mediated restoratio ...... s: prospects for gene therapy.
@nl
prefLabel
Adenovirus-mediated restoratio ...... s: prospects for gene therapy.
@en
Adenovirus-mediated restoratio ...... s: prospects for gene therapy.
@nl
P2093
P2860
P356
P1433
P1476
Adenovirus-mediated restoratio ...... s: prospects for gene therapy.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2008.13
P577
2008-03-28T00:00:00Z